Nagaland has not yet received Covid-19 vaccine doses to inoculate the people in the age group of 18 to 44 years in the State. The vaccination for this age group of people was planned from May 1.
The State Health and Family Welfare department on Friday said the vaccination of the age group of 18 to 44 years will commence only when the State receives the vaccine from the supplier.
Ready for a challenge? Click here to take our quiz and show off your knowledge!
It said so far, the State has received a letter from Serum Institute India saying that it will be supplying 36,580 doses of Covishield.
The department said the State Government is processing to procure four lakh doses to begin its third phase of Covid vaccination.
Though registration in the selfregistration.cowin.gov.in and AarogyaSetu App will continue to register new beneficiaries, the booking will for vaccination start only when the State announces the date for commencement of vaccination for the third phase for this age group, the department said.
Ready for a challenge? Click here to take our quiz and show off your knowledge!
Meanwhile, in partial modification of the Nagaland State Disaster Management Authority (NSDMA) order dated April 21, 2021, the state-level war room on Covid-19 has been restarted with the Chief Secretary and chairperson of the State Executive Committee, NSDMA, as the chairman and members from the key line departments.
The state-level control room will function at the Chief Secretary’s conference hall at Nagaland Civil Secretariat in Kohima and the required logistical arrangements will be supported by the NSDMA.
The state-level war room will ensure unity of command and control in the fight against Covid-19 in the State.
It will further ensure sharing of all relevant information on a real-time basis so that prompt and effective action is taken by the departments/officials/agencies concerned for preventing the spread of Covid-19 as well as for making interventions, whenever required, for strengthening the health infrastructure and the clinical management of the Covid-19 patients.